Sitagliptin compared to glimepiride on vascular risk factors among patients with type 2 diabetes mellitus - Trial SLCTR_2015_022
Access comprehensive clinical trial information for SLCTR_2015_022 through Pure Global AI's free database. This Phase 4 trial is sponsored by University Grants Commission, Sri Lanka and is currently status unknown. The study focuses on Type 2 Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2015_022
Phase 4
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2015_022
Sitagliptin compared to glimepiride on vascular risk factors among patients with type 2 diabetes mellitus
Effect of sitagliptin compared to glimepiride on vascular risk factors among patients with type 2 diabetes mellitus
Study Focus
Interventional
Sponsor & Location
University Grants Commission, Sri Lanka
Sri Lanka
Timeline & Enrollment
Phase 4
N/A
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2015_022
Non-Device Trial